HealthDay on MSN1d
Medicaid Expansion Increases Guideline-Concordant Treatment for Breast Cancer
Expanding Medicaid is associated with an increase in receipt of guideline-concordant treatment among nonelderly women newly ...
clinicaladvisor.com1d
Hormone Therapy for Breast Cancer
Hormone therapy (also called hormonal therapy or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce hormones or by interfering with the ...
Far Beyond Previous Estimates: Excess Body Fat Linked to 40% of Hormone-Positive Breast Cancer Cases
The proportion is significantly higher than that estimated using the commonly used Body Mass Index (BMI). Researchers suggest ...
Everyday Health9d
Excess Body Fat Strongly Linked to Hormone-Positive Breast Cancers
Increased body fat elevates estrogen production, potentially fueling growth of hormone-positive breast cancers, researchers ...
Obesity linked to hormone-positive breast cancers in older women
About 40% of hormone-positive breast cancers in postmenopausal women might be linked to excess body fat, researchers reported ...
FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...
oncnursingnews2d
ASCO Recommends Abemaciclib for High-Risk HR+, HER2- Breast Cancer
A nurse practitioner discusses ASCO’s recommendations of CDK4/6 inhibitors—namely abemaciclib and ribociclib—in certain ...
Healthline24d
Estrogen Receptor (ER) Positive Breast Cancer
According to the American Cancer Society (ACS), about 2 out of every 3 cases of breast cancer are hormone receptor-positive. Most of these cases are ER-positive, meaning that there are estrogen ...
Novartis ribociclib recognized as Category 1 treatment by NCCN Guidelines
This month, the NCCN Clinical Practice Guidelines in Oncology, NCCN Guidelines, for breast cancer were updated to recommend ribociclib as a ...
EurekAlert!1mon
Challenge of weight gain in hormone receptor-positive breast cancer
over time among early-stage breast cancer survivors with hormone receptor (HR)-positive breast cancer. A secondary goal was to determine whether an interaction between race and BMI existed that ...
Endocrinology Advisor3d
Excess Adiposity Plays Role in Postmenopausal HR-Positive Breast Cancer
Excess body fat plays a role in postmenopausal hormone receptor-positive breast cancer, which could be underestimated using only body mass index (BMI). HealthDay News — Excess body fat plays a role in ...